Validation of Smart Nanoparticles as Controlled Drug Delivery Systems: Loading and pH-Dependent Release of Pilocarpine by Galbis Fuster, Elsa et al.
Validation of Smart Nanoparticles as Controlled Drug Delivery
Systems: Loading and pH-Dependent Release of Pilocarpine
Elsa Galbis,† Nieves Iglesias,† Ricardo Lucas,† Ernesto Tinajero-Díaz,‡ M.-Violante de-Paz,*,†
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ABSTRACT: Micelles are good devices for use as controlled
drug delivery systems because they exhibit the ability to
protect the encapsulated substance from the routes of
degradation until they reach the site of action. The present
work assesses loading kinetics of a hydrophobic drug,
pilocarpine, in polymeric micellar nanoparticles (NPs) and
its pH-dependent release in hydrophilic environments. The
trigger pH stimulus, pH 5.5, was the value encountered in
damaged tissues in solid tumors. The new nanoparticles were
prepared from an amphiphilic block copolymer, [(HEMA19%-
DMA31%)-(FMA5%-DEA45%)]. For the present research, three
systems were validated, two of them with cross-linked cores
and the other without chemical stabilization. A comparison of
their loading kinetics and release proﬁles is discussed, with the support of additional data obtained by scanning electron
microscopy and dynamic light scattering. The drug was loaded into the NPs within the ﬁrst minutes; the load was dependent on
the degree of cross-linking. All of the systems experienced a boost in drug release at acidic pH, ranging from 50 to 80% within the
ﬁrst 48 h. NPs with the highest degree (20%) of core cross-linking delivered the highest percentage of drug at ﬁxed times. The
studied systems exhibited ﬁne-tuned sustained release features, which may provide a continuous delivery of the drug at speciﬁc
acidic locations, thereby diminishing side eﬀects and increasing therapeutic rates. Hence, the studied NPs proved to behave as
smart controlled drug delivery systems capable of responding to changes in pH.
■ INTRODUCTION
The use and development of micro/nanostructures in smart
drug/gene delivery systems have caught the attention of the
research community for the last two decades or so, and some
interesting reviews have summarized the last trends in this
ﬁeld.1−3 The controlled drug delivery is not only advantageous
in suppressing the side eﬀects of the toxic drugs but also in
overcoming the drawbacks of insoluble drugs, especially of
anticancer molecules such as doxorubicin.4 Among the most
promising systems, organic nanoparticles (NPs) are being
widely studied. The formation of organic nanoparticles can be
achieved not only by the self-assembly of two mixed
components of opposed hydrophilic/hydrophobic nature5 but
also by the use of amphiphilic block copolymers, leading to
nanosized micelles.6 By ensuring the homogeneity of the
generated nanoparticles, the latter method allows the reliable
preparation of formulations widely used in varied ﬁelds, from
drug delivery, biosensors, and gene therapy to cosmetics,
among others.2,7
In the face of common drawbacks in therapeutic treatments,
such as the diﬃculty of getting the drug across biological
barriers and reaching the damaged tissue or the degradation
that takes place once the drug enters the organism, smart
nanosized systems have become the option of choice. The
internal hydrophobic nature of the NPs would protect the drug
against the degradative environment on its way to the biological
target.
Micelles from diblock copolymers are one of the most
popular drug delivery systems (DDS), leading to core−shell
micelles, which are able to transport lipophilic molecules into
its core.1,8 ABC triblock copolymers are another option which
leads to the formation of core−shell−corona micelles. The
presence of a highly hydrophilic corona layer makes them very
stable in aqueous media.4,9 Methacrylate esters,10 poly(ethylene
glycol),4,11 and chitosan12 among others are the most common
hydrophilic segments, and regarding the hydrophobic blocks,
polycaprolactone,4 poly(propylene oxide),13 poly-
(dimethylsiloxane),10 ciclodextrins,2,11and other methacrylate
derivatives14 can be found.
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Moreover, the so called smart NPs can be designed in such a
way that they respond to changes within the human body as a
means of boosting the drug concentration where it is required.
One highly useful trigger stimulus is the reduction in pH
commonly encountered in cancerous tissues of solid tumors.
The presence of tertiary amine groups in the block copolymers
imparts pH-responsive properties to the ﬁnal micelles, as has
recently been conﬁrmed.15 However, the dynamic, reversible
nature of micelle formation is a source of instability. As the
micelles can be dissociated at low concentrations (below its
critical micelle concentration), the premature drug release at
normal tissues or organs may be accelerated, prompting serious
side eﬀects.4 The disruption of NPs by dilution can be
prevented if they are properly cross-linked, either in the shell,
or in the core,16 leading to stable unimolecular NPs, the former
option being the most widely investigated. The core cross-
linking approach circumvents the potential intermicellar
reaction because the hydrophilic block in the shell acts by
minimizing the chain overlap between adjacent micelles via a
steric stabilization mechanism, thus preventing intermicelle
cross-linking.17
Our research group has carried out the preparation of smart,
pH-responsive core cross-linked NPs as potential DDS,15 and
the aim of the present work is the validation of these NP
dispersions as drug carriers able to control the release of an
active lipophilic molecule upon a trigger stimulus. As far as the
authors are aware, this is the ﬁrst time that the inﬂuence of the
degree of core cross-linking in the uptake and release of a
hydrophobic drug has been investigated in NPs used as DDS.
Pilocarpine, a hydrophobic drug, was the molecule of choice.
The uptake kinetics of the drug by cross-linked and non-cross-
linked systems were compared, as well as its release under
various conditions. The ﬁndings were supported by data
collected from scanning electronic microscopy (SEM), dynamic
light scattering (DLS), UV−visible spectroscopy, and other
techniques.
■ RESULTS AND DISCUSSION
Preparation of NPs from the Autoassembly Block
Copolymer [(DMA31% HEMA19%)-block-(DEA45%-FMA5%)]
(Samples S1, S2, and S3). The preparation of the amphiphilic
block copolymer used in the present work has been published
elsewhere15 and is summarized in Scheme 1. The synthesis was
carried out by the widely used atom transfer radical
polymerization (ATRP) at ambient temperature, a “living”
polymerization procedure that allows the reliable formation of
block copolymers by means of one-pot reactions. In this case,
the hydrophilic block, constituted by N,N-dimethylaminoethyl
methacrylate (DMA) and 2-hydroxyethyl methacrylate
(HEMA) monomers, was formed ﬁrst, followed by the
subsequent addition of the hydrophobic monomers N,N-
diethylaminoethyl methacrylate (DEA) and furfuryl methacry-
late (FMA), leading to the formation of the hydrophobic block.
The experimental copolymer composition (in mole percent-
age), determined by proton nuclear magnetic resonance (1H
NMR), was found to be [(DMA31% HEMA19%)-block-(DEA45%-
FMA5%)]. The values of molecular weights and polydispersity
were calculated by gel permeation chromatography and were
found to be Mn = 34 700; Mw = 45 100; and Mw/Mn = 1.3.
The autoassembly features of that copolymer in aqueous
media were studied. The properties of the generated NPs, such
as size, polydispersity, shape, and critical micelle concentration
(CMC),18,19 were explored by means of various techniques:
Scheme 1. One-Pot Synthesis of Methacrylate-Based Block Copolymers by ATRPa
aInitiator: ethyl-2-bromo-2-methylpropionate (EBiB); catalyst: CuBr; ligand: 2,2′-bipyridyl (bipy).
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SEM, DLS, UV−vis spectroscopy, and others. The CMC value
(0.078 mg/mL) demonstrates the great tendency to self-
assemble into micelles in aqueous media. Accordingly, well-
deﬁned micelles were formed at pH 7.0 (Figure 1A) when the
polymer concentration stood at 0.25 mg/mL (sample S1). The
hydrophobic blocks, formed by DEA/FMA moieties, con-
stituted the dehydrated micelle cores,17 leaving the hydrophilic
blocks (formed by DMA and HEMA moieties) in the outer
part of the NPs in contact with the aqueous medium.
The disruption of these micelles can be a priori boosted by
dilution or under acidic environment (Figure 1B). The use of a
cross-linker can lead to the formation of covalent bonds
between the furan moieties present in the core (Figure 1C).
Thus, the micellization would become irreversible once the
cross-linking reaction took place, making them stable under
those conditions, whether at high dilution or at acid pH (Figure
1D). Consequently, another two systems were prepared at the
same polymer concentration, with the aim of core cross-linking
the micelles and hence obtaining stable NP dispersions. To
accomplish this requires a simple, fast, and reliable reaction
with some speciﬁc features (e.g., high yields and absence of side
products). Those reactions that meet such attributes are
grouped under the denomination of click reactions, the Diels−
Alder reaction being one of them. One of the most widely used
Diels−Alder reactions is that involving a maleimide ring and a
furan ring.20 Thus, furan rings present in the micellar core
would react in pairs with the two maleimide groups from the
freshly prepared cross-linker (1,8-dimaleimide-3,6-dioxaoctane,
DMDOO). The degree of cross-linking was ﬁxed in these
assays (sample S2 with 20% of cross-linking, and sample S3
with 10% of cross-linking) so that two dispersions of stable NPs
were achieved (Figure 1C).
Size and Shape Morphology of NPs S1−S3 and
Stability at pH 5.5 (ac-S1 to ac-S3). The shape and surface
morphology of prepared NPs were evaluated by SEM and DLS.
The studies revealed that most of the NPs were fairly spherical
in shape. Studies carried out on S1 demonstrated the formation
of dispersions with a low polydispersity index (PdI, 0.14) and
average hydrodynamic diameter (Dh) by DLS of 210 nm
(Table 1). As far as the dispersions S2 and S3 are concerned,
the cross-linking of the NPs resulted in a minor increase in PdI
in both assays (to values close to 0.3), with the main population
of NPs (95% of the total) at just over 100 nm (Table 1). The
analyses of SEM images revealed, ﬁrst, that the average particle
sizes of samples S1, S2, and S3 were 95, 49, and 65 nm,
respectively, which evidenced an overestimation of NPs’ sizes
by DLS. On the other hand, a signiﬁcant reduction in size
(between 31 and 48% from SEM data) was observed for the
cross-linked NPs, in comparison with sample S1.
The pH of the media and the drug loading displayed a
marked impact on the NP size. At acidic pH, not only did the
cross-linked NPs (ac-S2 and ac-S3) undergo a dramatic
increase in size (from 5 to 10 times) but this eﬀect was also
dependent on the degree of cross-linking. The same trend was
also encountered when loading NPs were analyzed (LS1, LS2,
and LS3). This observation is well depicted in Figures 2 and 3
and discussed below.
The success of the stabilization process was investigated by
both dilution and treatment at acidic pH. When dispersions
were diluted with dimethylformamide to concentrations below
CMC, the only samples that remained stable were those with
Figure 1. (A) Micelles from autoassembly of the amine-containing amphiphilic block copolymers in aqueous media (nonstabilized micelles); (B)
solution of protonated polymer chains, (C) stabilized NPs by core cross-linking; and (D) stable amine-containing NPs with hydrophilic and
hydrated core.
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core cross-linking (S2 and S3), validating the success of the
coupling reactions.15
The samples were studied at pH 5.5 and 37 °C to reproduce
the physiological conditions of pH and T to check the integrity
of the NP structures in an acidic environment similar to that of
damaged or targeted tissues in the human body. It was expected
that the presence of DMA and DEA repeating units would
make possible the protonation of both the shell and the core of
the NPs. In the event that the micelles were not cross-linked,
the electrostatic repulsion between the polymer chains would
make them ﬂy apart (Figure 1B). Notwithstanding, protonation
in the core should not be capable of breaking the three-
dimensional structure, and NPs with hydrated and hydrophilic
cores could be obtained, leading to fully hydrophilic NPs
(Figure 1D).
The experimental trials were conducted immersing the NPs
in a buﬀered solution at pH 5.5 (samples ac-S1, ac-S2, and ac-
S3). The ﬁndings from both DLS studies and SEM images
(Table 1, Figures 2 and 3) conﬁrmed that all of the dispersions
remained stable at acidic pH, including that of the nonstabilized
NPs ac-S1. Unexpectedly, and as conﬁrmed by SEM images
(Figure 2a), protonation of the polymer in sample ac-S1 was
not capable of breaking up the micelles, which kept their
integrity. This behavior may be due to the diﬃculties
encountered by the acidic water solution to enter the core of
the micelles and then protonate the basic residues of the DEA
units, leading to a polymer solution. Besides, it is hypothesized
that the high number of hydroxyl groups from HEMA moieties
present in the hydrophilic blocks partially prevented the
electrostatic repulsion between the cationic charges in the shell
of the micelles, keeping them intact at acidic pH.
In addition, the study of the three parameters, Z-average,
mean size (Dh) calculated by DLS, and mean size calculated
from SEM images (Figure 3), showed that the cross-linked
samples increased in size at acid pH (Table 1). The values for
sample ac-S2 (with 20% of cross-linking) were signiﬁcantly
higher than those for sample ac-S3 (with 10% of cross-linking).
Conversely, the increase in size of the non-cross-linked NPs
was insigniﬁcant.
The latter ﬁndings could be explained on the grounds of the
excellent packing eﬃciency of the polymer chains in the
nucleus in nonstabilized NPs (S1/ac-S1), which would be
impeded by the reaction of the bismaleimide DMDOO with
the furan moieties in the nucleus of samples S2/ac-S2 and S3/
ac-S3. The length of the cross-linker and the formation of two
bulky tricyclic systems (Figure 4) can hinder, to some extent,
the packing of the polymer hydrophobic segments in the core
of the NPs. This eﬀect is greater when the degree of cross-
linking is 20%, leading to looser cores in samples ac-S2 and
LS2. Consequently, the latter samples, with looser cores, enable
entry of the aqueous medium into the core of the NPs. This
feature had a great impact not only on the ﬁnal size of the NP
at pH 5.5 but also on both the loading kinetics and the
percentage of drug released from each system, as described
below. All in all, the dispersions S2 and S3 were stable for
months, in a wide range of pH (from pH 3.0 to pH 8.0) and at
high dilutions. This is supported by the study of an important
colloid property, zeta potential. The samples were titrated and
z-potential measured. The values were in the range from 45 to
60 mV, at acid pH, which also demonstrated the excellent
stability of the prepared NPs. This remarkable stability might
be attributed to the hydrophobic cross-linking cores and the
steric hindrance from the hydrophilic corona. These ﬁndingsT
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support the conclusion that the prepared NPs could be
promising candidates for drug delivery applications.
Loading Kinetics of Pilocarpine by the Novel
Dispersions (Samples LS1−LS3). When the loading
capability of the lipophilic molecules had been conﬁrmed for
the studied NPs,15 some drug-uptake assays were carried out,
using pilocarpine as the molecule of choice. Pilocarpine is a
therapeutic molecule (online resource 1, Figure S1) with low
water solubility and is used clinically as co-drug in glaucoma
and xerostomia, as well as in the treatment of head and neck
cancer; it is also prescribed against Sjögren’s syndrome. Salivary
gland hypofunction, commonly developed during radiation
therapy for head and neck cancer and in patients with Sjögren’s
syndrome,21 leads to diminished secretions and the acidiﬁcation
of saliva. This latter characteristic would aﬀect the regular
homeostasis of the oral cavity, leading not only to speciﬁc
changes in the salivary bacterial proﬁles22 but also to
demineralization of the tooth enamel, with the consequent
increase in the risk of caries.23 In this context, because it can
stimulate salivary tissues, pilocarpine is used to reduce the
severity of xerostomia and salivary dysfunction. The incorpo-
ration of pilocarpine into pH-sensitive NPs allows the drug to
be released under such acidic environments and exert its
therapeutic activity.
Previous to the pilocarpine-loading studies, two linear
regression analyses were conducted at pHs 7.0 and 5.5 to
ascertain the relationship between pilocarpine concentration in
aqueous solutions and its absorbance at 215 nm in UV
spectroscopy (online resource 1, Figure S2). The regression
analysis quantiﬁed the ﬁnal concentration of pilocarpine in the
media during the uptake and delivery assays.
The loading experiments were conducted at pH 7.0 and 25
°C, with a drug−polymer ratio equal to 0.8 mg of pilocarpine/
mg of polymer. The drug was added, and the dispersions were
analyzed at speciﬁc times. The loading of the drug by non-
cross-linked and cross-linked systems was monitored for 144 h
(Figure 5, assays LS1, LS2, and LS3 for non-cross-linked, 20
and 10% cross-linked NPs, respectively).
The interactions among the NPs and the drug were expected
to be hydrophobic due to the chemical structure of the drug,
and therefore the drug may be allocated into the core of the
NP. This is supported by previous assays in which another
hydrophobic and ﬂuorescent molecule, pirene, was embedded
into NPs and was conﬁrmed by ﬂuorescence microscopy as well
as by an extensive research carried out by other authors.15,24,25
The interaction of pilocarpine with the NPs at neutral pH
provoked a signiﬁcant drop in absorbance at 215 nm in 30 min
(Figure 5A), probably due to the alteration of the excited
electronic states of the drug (with impinge on the ε parameter).
Thus, the nonloaded pilocarpine that remained in the medium
may be largely responsible for the absorbance ﬁgures at 215
nm.
Figure 2. Selected SEM images of the NP systems at pH 5.5 prepared from the block copolymer (DMA31% HEMA19%)-block-(DEA45%-FMA5%)
synthesized by ATRP: (a) non-cross-linked NP (ac-S1); (b) core cross-linked NP with 20% of degree of cross-linking (ac-S2).
Figure 3. Comparison of mean NP sizes determined by DLS and SEM
at pHs 7.0 and 5.5 (from left to right: samples S1, ac-S1, S2, ac-S2, S3,
ac-S3; here “ac” denotes NPs dispersed in an acidic medium at pH 5.5,
“XL” denotes cross-linked NPs and “20%” and “10%” the degree of
cross-linking).
Figure 4. Diels−Alder adduct formed by the reaction of two furan
rings from furfuryl methacrylate units present in the core with the
cross-linker 1,8-dimaleimide-3,6-dioxaoctane (DMDOO).
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Therefore, the percentage of uploading was determined using
the eq 1
= − ×uploading (%) drug conc residual drug conc
drug conc
100t0
0
(1)
where uploading (%) is the entrapped pilocarpine into the NPs
in percentage, drug conc0 is the initial amount of pilocarpine at
time = 0 (μg drug/mL) in the media and residual drug conct is
the concentration of pilocarpine in the media at time = t (μg
drug/mL). This last value was calculated using the eq 2, the
equation being obtained experimentally from the calibration
curve of pilocarpine (online resource 1, Figure S2).
= Aresidual drug conc /0.0227t (2)
where A is the absorbance of the sample at 215 nm and 25 °C.
As a result, being lipophilic enough to eﬃciently bind
pilocarpine, the NP cores removed the drug from the aqueous
environment quickly. The ﬁndings also demonstrated that
nonetheless the uptake is a dynamic procedure, and hence a
period of stabilization of 48 h was required. This is especially
important when cross-linked NPs were studied. Figure 5A
displays this eﬀect for samples LS2 and LS3. Consequently,
some extra time was required to report reliable results that they
were not time dependent. Conversely, once steady, the NP−
drug complexes were stable for months within a wide range of
temperature, from 5 to 40 °C.
Despite pilocarpine’s loading eﬃciency being above 80% w/
w in all cases (Figure 5B), a signiﬁcant dissimilarity was
observed between the non- and the cross-linked NPs. Thus, for
example, pilocarpine was almost completely removed from the
medium in LS2 and LS3 (the percentage of remaining
pilocarpine was 3.5 and 2.4%, respectively), whereas just
under 20% of the added pilocarpine (18%) remained in the
medium without being captured by the nonstabilized NPs
(LS1). Another relevant feature encountered was that the
absorbance versus time curves for the uploading trials did not
converge at long times, supporting the fact that those three
systems behave diﬀerently as nanocarriers.
In addition, and assuming that the presence in the core of the
adduct formed between the furan rings and the cross-linker
DMDOO in samples LS2 and LS3 (higher ratio in the former)
provides some steric hindrance and prevents the lipophilic
segments of the block copolymer being tightly organized, the
higher the degree of cross-linking is, the looser the cores will
become. These ﬁndings demonstrated the relevance not only of
the stabilization of the NPs but also of their percentage of
cross-linking. On the basis of the hypothesis mentioned above,
it seems that the higher the degree of cross-linking is, the higher
is the free volume encountered into the core. As the drug tends
to enter in the core of the NPs due to its hydrophobic nature,
this could be easier once the free volume is boosted by any
reason. As a result, the incorporation of the therapeutic
molecule was enhanced in samples LS2 and LS3. This
Figure 5. Kinetic studies at 25 °C of pilocarpine loading in NPs by UV−vis spectroscopy at 215 nm (initial pilocarpine concentration = 0.1 mg/mL;
polymer concentration = 0.125 mg/mL). (A) Absorbance of free pilocarpine in NP dispersion vs time; (B) cumulative percentage of pilocarpine
embedded into the NPs vs time, calculated from absorbance values at 215 nm.
Figure 6. Release of pilocarpine (related to the entrapped pilocarpine into the NPs, in percentage) vs time from pilocarpine-loaded NPs at pHs 7.0
and 5.5 at 37 °C (polymer concentration: 0.125 mg/mL).
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conclusion is supported by size studies of loaded NPs by DLS
(Table 1). In general terms, loaded NPs at pH 7.0 (samples
LS1, LS2, and LS3) display higher values of Z-average and
mean size (Dh) than unloaded NPs under the same conditions
(samples S1, S2, and S3). The most outstanding aspects of
these ﬁgures are that both Z-average and mean size markedly
increased in loaded cross-linked NPs (samples LS2 and LS3),
doubling and almost tripling their values compared with those
of the unloaded counterparts at neutral pH. With regards to the
uploading values encountered for LS2 and LS3, although being
quite similar, the presence of more hydrophilic oligoethylene
glycol chains of the cross-linker (Figure 4) in LS3 could
diminish to some extent the aﬃnity of the drug for the core in
that sample compared to that in LS2.
Pilocarpine Release from Drug-Loaded NPs under a
Trigger Stimulus (Samples RS1−RS3). The last part of the
present work was focused on evaluating the release of
pilocarpine from the NPs at neutral pH and in response to
the acidiﬁcation of the aqueous media. The acidic pH was set at
5.5 as this value corresponds to the pH encountered in oral
secretions during the treatment of head and neck cancer, as well
as in patients with Sjögren’s syndrome. The NPs were
immersed in a buﬀer solution (either phosphate buﬀer pH
7.0; or phosphate buﬀer pH 5.5). The drug content was
evaluated by UV−vis measurements at 215 nm, using the
unloaded NPs as blank. The cumulative pilocarpine release
proﬁles from NPs at pHs 7.0 and 5.5 are shown in Figure 6.
The percent of drug release was determined using eq 3
=
−
×
m m
m
Drug release(%) 100tentrapped(0) residual( )
entrapped(0) (3)
where mentrapped(0) is the weight of initial entrapped pilocarpine
into the NPs; mresidual(t) is the weight of residual pilocarpine at
time “t” into the nanocarriers.
For these trials, the use of normalized data was made to
compare the capacity of the systems studied to retain or not the
drug into the NPs at diﬀerent pHs. At neutral pH and from the
normalized values of the drug released from the NPs, some
liberation was found in every case, being low for the systems
RS1 and RS3, in which most of the drug remained in the NPs.
These ﬁndings support the hypothesis that on one hand, the
looser the core of the NP is, the easier is the diﬀusion of the
drug to the media, this fact being more marked in the case of
sample RS2, and on the other hand, the drug could be present
not only in the NP core but also in the shell. Although it could
be wrongly inferred from a quick view of Figure 6 that non-
cross-linked NPs (RS1) are better than 10% cross-linking NPs
(RS3) on releasing the drug, this was not the case.
When the loaded NPs were exposed to the trigger stimulus,
i.e., the acidiﬁcation of the media to pH 5.5, a boost in the drug
release was observed in all systems. The protonation of the
tertiary amine groups of DMA and DEA residues took place,
and, as a result, the core became hydrophilic, allowing entry of
the aqueous media. Consequently, the pilocarpine was no
longer enclosed in a lipophilic environment and between some
50 and 80% of the drug content was released in 48 h,
depending on the system. To have a better understanding of
the release kinetics of the drug in the three studied systems, in
the case of cross-linked NPs (RS2 and RS3), the most
signiﬁcant fact was that the more cross-linked the NP, the
higher the observed percentage of release at ﬁxed times. Once
more, how loosely entangled the core was, played a crucial role
in the performance of the NPs as drug delivery systems.
Interestingly, release ﬁgures from trials of non-cross-linked NPs
(RS1) were higher than those from trials of RS3 throughout the
studied period of time. It is hypothesized that some disruption
of the micellar structure might have taken place, causing
liberation of the drug into the media, conﬁrming the beneﬁts
associated with the cross-linking in the NPs formed.
■ CONCLUSIONS
Three NP systems prepared from a new amphiphilic self-
assembled block copolymer, one of them nonstabilized and the
other two stabilized by means of core cross-linking, have been
investigated in terms of their drug loading and release capacities
under physiological conditions. The shape and structure of all
of them were evaluated at pH 7.0 and pH 5.5 by scanning
electron microscopy (SEM) and dynamic light scattering
(DLS). At pH 7.0, NPs in the range from 100 to 200 nm
with low polydispersities were found. Trials conducted in acidic
media conﬁrmed the integrity of the NP structures at pH 5.5,
and an increase in size was observed.
The loading of pilocarpine into the NPs has proved to be
both a highly eﬃcient and dynamic procedure, with really fast
loadings within the ﬁrst few minutes, and the NP−drug
complexes were stable for months. It was observed that the
higher the degree of cross-linking is, the higher is the amount of
pilocarpine loaded into the NPs. Moreover, the Z-average and
mean size of loaded NPs doubled and almost tripled in value
for stabilized systems, giving weight to the observations
mentioned above. Regarding the drug-release behavior, all of
the systems experienced a boost in drug release at acidic pH,
ranging from 50 to 80% within the ﬁrst 48 h. NPs with 20% of
core cross-linking delivered the highest percentage of drug at
ﬁxed times. Also signiﬁcant were the release values from the
non-cross-linked NPs, which may be due to some micellar
disruption in the media.
The ﬁne-tuned sustained release features encountered in the
studied systems may provide a continuous delivery of the drug
at speciﬁc acidic locations. Thereby, problems associated to
cyclic variations in drug concentration in blood versus time may
be averted, oﬀering a maximum pharmacological eﬃciency at a
minimum drug dose.
■ EXPERIMENTAL SECTION
The detailed procedures for the preparation of micelles by self-
assembly, stabilization in the core, loading, and release assays,
as well as all characterization techniques are available in the
Supporting Information.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acsomega.7b01421.
Materials and methods (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: vdepaz@us.es.
ORCID
Elsa Galbis: 0000-0001-8521-2835
Nieves Iglesias: 0000-0003-0201-883X
M.-Violante de-Paz: 0000-0002-6544-4732
ACS Omega Article
DOI: 10.1021/acsomega.7b01421
ACS Omega 2018, 3, 375−382
381
Juan A. Galbis: 0000-0001-8662-2852
Author Contributions
The manuscript was written through contributions of all
authors. All authors have given approval to the ﬁnal version of
the manuscript.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
The authors would like to thank the Ministerio de Economiá y
Competitividad (Grant MAT2016-77345-C3-2-P) and the
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